You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID-19 Booster

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Vaccines Trial in Los Angeles (Reminder to boost protection against COVID-19, Flu Tag Along, COVID-19 Booster & Flu

Recruiting
  • COVID-19
  • Vaccines
  • Reminder to boost protection against COVID-19
  • +2 more
  • Los Angeles, California
    UCLA Health Department of Medicine, Quality Office
Nov 4, 2022

Booster Message, Booster Message + Financial Incentive Trial in Martinez (Messaging, Financial Incentive, Placebo)

Recruiting
  • Booster Message
  • Booster Message + Financial Incentive
  • Messaging
  • +2 more
  • Martinez, California
    Contra Costa Health Plan
Dec 31, 2022

COVID-19, Vaccines Trial in Los Angeles (Reminder that facilitates action, Consistency framing, Information provision about the

Recruiting
  • COVID-19
  • Vaccines
  • Reminder that facilitates action
  • +4 more
  • Los Angeles, California
    UCLA Health Department of Medicine, Quality Office
Nov 8, 2022

COVID-19 Trial in United States (Vaccine Messaging, Vaccine Acceptance Question)

Not yet recruiting
  • COVID-19
  • Vaccine Messaging
  • Vaccine Acceptance Question
  • San Francisco, California
  • +6 more
Dec 1, 2023

Effect of a Third COVID-19 Booster Among Health Care Workers

Not yet recruiting
  • COVID-19 Vaccines
  • Third COVID-19 booster
  • Hong Kong, Hong Kong
    Hong Kong Sanatorium & Hospital
May 16, 2022

Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

Terminated
  • Anti-SARS-CoV-2 Antibody Response
  • blood and saliva samples will be taken
  • Graz, Austria
    Medizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023

COVID-19, Vaccines Trial in Los Angeles (Eligibility reminder, Link to a narrow set of vaccine venues, Link to a broad set of

Recruiting
  • COVID-19
  • Vaccines
  • Eligibility reminder
  • +3 more
  • Los Angeles, California
    UCLA Health Department of Medicine, Quality Office
Nov 8, 2022

Assess Immunogenicity of Nationally Authorized Homologous

Not yet recruiting
  • COVID-19
  • Immune Responses
  • (no location specified)
Jan 31, 2023

COVID Booster in Pregnancy and Lactation

Recruiting
  • COVID-19
  • Bivalent COVID-19 Booster
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 14, 2022

Vaccine Refusal, COVID-19 Trial (Informational Video, Altruistic Video, Individualistic Video)

Not yet recruiting
  • Vaccine Refusal
  • COVID-19
  • Informational Video
  • +2 more
  • (no location specified)
Apr 12, 2023

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Completed
  • COVID-19
  • +2 more
  • Observational
  • New York, New York
    AHD Manhattan Midtown HCC
Jul 26, 2022

COVID-19 Vaccines Trial in Marshfield (Reminder/Recall Sent Via Preferred Method of Communication)

Active, not recruiting
  • COVID-19 Vaccines
  • Reminder/Recall Sent Via Preferred Method of Communication
  • Marshfield, Wisconsin
    Marshfield Clinic Health System
Oct 10, 2022

COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)

Not yet recruiting
  • COVID-19
  • Bivalent Moderna
  • Novavax
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023

COVID-19 Booster Vaccine in Type 1 Diabetes

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • CGM
  • Columbia, Maryland
    Cardiovascular Specialists of Central Maryland
Apr 7, 2022

COVID-19 Vaccination Trial in Hong Kong (BNT162b2, CoronaVac)

Active, not recruiting
  • COVID-19 Vaccination
  • BNT162b2
  • CoronaVac
  • Hong Kong, Hong Kong
    The University of Hong Kong
Feb 8, 2022

Rheumatoid Arthritis Trial in Seoul (MTX)

Recruiting
  • Rheumatoid Arthritis
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 4, 2022

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

COVID-19 Trial (Invitation to get a 2nd booster dose of COVID-19 vaccine)

Not yet recruiting
  • COVID-19
  • Invitation to get a 2nd booster dose of COVID-19 vaccine
  • (no location specified)
Sep 14, 2022

Multiple Sclerosis Trial in Derby (Homologous booster, Heterologous booster)

Recruiting
  • Multiple Sclerosis
  • Homologous booster
  • Heterologous booster
  • Derby, Connecticut
    Griffin Hospital
Jan 23, 2022

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)

Not yet recruiting
  • COVID-19
  • Intramuscularly administered Ad5-nCoV vaccine
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 10, 2023